3CALRINA A I,LAMPA J,EMESLAMMESLAM S,et al.Anti-tumour necrosis factor(TNF)-alpha therapy (elanercept)down-regulates serum Matrix metalloproleinase (MMP)-3 and MMP-1 in rheumatoid arthritis[J].Rheumatology (Oxford),2002,41(4):484-489.
4TAYSI S,POLAT F,GUL M,et al.Lipid peroxidation,some extracellar antioxidant enzymes in serum of patients with rheumatoid arthritis[J].Rheumatol Int,2002,21(5):200-204.
二级参考文献9
1Reboul P, Pelletier JP, Tardif G, et al. The new collagenase,collagenase - 3, is expressed and synthesized by human chondrocytes but not by synoviocytes, A role in the osteoarthritis. J Clin Invest, 1996, 97(9) :2011-9.
2Cawston T, Billington C, Cleaver C, et al. The regulation of MMPs and TIMPs in cartilage turnover.Ann NY Acad Sci,1999, 878:120--9.
3Flannery CR, Little CB, Caterson B, et al. Effects of culture conditions and exposure to catabolic stimulators(IL- 1 and retinoic acid) on the expression of matrix metalloproteinases(MMPs)and disintegrin metalloproteinases(ADAMs)by articular cartilage chondrocytes. Matris Biol, 1999, 18(3) : 225-37.
4Keyszer G, Lambiri I, Nagel R, et al. Circulating levels of matrix metalloproteinases MMP - 3 and MMP - 1, tissue inhibitor of metalloproteinases 1(TIMP- 1) and MMP- 1/ TIMP- 1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.J Rheumatol, 1999, 26(2) : 251-8.
5Wu CW, Tchtina EV, Mwale F, et al. Proteolysis involving matrix metalloproteinase 13(collagenase - 3) is required for chondrocyte differentiation that is associated with matrix mineralization. J Bone Miner Res, 2002, 17(4) : 639--51.
6Posthumus MD, Limburg PC, Westra J, et al. Serum levels of matrix metalloproteinase - 3 in relation to the development of radiological damage in patients with early rheumatoid arthritis. Rheumatology(Oxford), 1999, 38(11) : 1081--7.
7Martel-Pelletier J, McCollum R, Fujimoto N, et al. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest, 1994, 70(6) : 807-15.
8Naito K, Takahashi M, Kushida K, et al. Measurement of matrix metalloproteinases(MMPs) and tissue inhibitor of etalloproteinases- 1(TIMP- 1)in patients with knee oateoarthritis:Comparisonwith generalized osteoarthritis. Rheumatology(Oxford), 1999, 38(6) :510--54.
10Karatas F, Ozates I, Canatan H, et al.Antioxidant status & lipid peroxidation in patients with rheumatoid arthritis[J]. lndian JMedRes, 2003,118( 1 ) : 178.
